Efficacy and safety of pegylated-interferon alpha therapy in patients with chronic hepatitis B in recource-limited settings- Serbian single-center experience

Autor: Bojović Ksenija, Jordović Jelena, Simonović-Babić Jasmina, Delić Dragan, Mitrović Nikola, Katanić Nataša

Publikováno v: Vojnosanitetski Pregled, Vol 77, Iss 8, Pp 796-803 (2020)

Background/Aim. In Serbia, pegylated interferon (PEGIFN) alpha-2a has been registered since 2013 for the treatment of patients with chronic hepatitis B (CHB). Numerous advantages, new experiences during the past five years and lack of any published d

Externí odkaz: https://doaj.org/article/4beda5d2f42a414aa04921af95beb311

The importance of haematological and biochemical findings in patients with West Nile virus neuroinvasive disease

Autor: Urošević Aleksandar, Dulović Olga, Milošević Branko, Maksić Nebojša, Popović Nataša, Milošević Ivana, Delić Dragan, Jevtović Đorđe, Poluga Jasmina, Jordović Jelena, Peruničić Sanja, Stevanović Goran

Publikováno v: Journal of Medical Biochemistry, Vol 35, Iss 4, Pp 451-457 (2016)

Background: West Nile virus neuroinvasive disease (WNND) occurs in less than 1% of infected people. Leukocytosis with lymphocytopenia, mild anaemia, thrombocytopenia, elevated liver and muscle enzymes and hyponatremia are occasionally present in pati

Externí odkaz: https://doaj.org/article/469d7d09472040c791987e90c1052815

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Significance of UGT1A1 *28 Genotype in Patients with Advanced Liver Injury Caused By Chronic Hepatitis C.

Autor: Jordovic J; Clinic for Infectious and Tropical Diseases, Clinical Centre of Serbia, Belgrade, Serbia., Bojovic K; Clinic for Infectious and Tropical Diseases, Clinical Centre of Serbia, Belgrade, Serbia.; Medical Faculty, University of Belgrade, Belgrade, Serbia., Simonovic-Babic J; Clinic for Infectious and Tropical Diseases, Clinical Centre of Serbia, Belgrade, Serbia.; Medical Faculty, University of Belgrade, Belgrade, Serbia., Gasic V; Laboratory for Molecular Biomedicine, Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, Belgrade, Serbia., Kotur N; Laboratory for Molecular Biomedicine, Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, Belgrade, Serbia., Zukic B; Laboratory for Molecular Biomedicine, Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, Belgrade, Serbia., Vukovic M; Department for Medical Genetics, University Clinical Centre of the Republic of Srpska, Banja Luka, Bosnia and Hercegovina., Pavlovic S; Laboratory for Molecular Biomedicine, Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, Belgrade, Serbia., Lazarevic I; Medical Faculty, University of Belgrade, Belgrade, Serbia., Bekic I; Institute for Oncology and Radiology of Serbia, Belgrade, Serbia., Nikolic N; Clinic for Infectious and Tropical Diseases, Clinical Centre of Serbia, Belgrade, Serbia.; Medical Faculty, University of Belgrade, Belgrade, Serbia., Uroševic A; Clinic for Infectious and Tropical Diseases, Clinical Centre of Serbia, Belgrade, Serbia.; Medical Faculty, University of Belgrade, Belgrade, Serbia., Mitrovic N; Clinic for Infectious and Tropical Diseases, Clinical Centre of Serbia, Belgrade, Serbia.; Medical Faculty, University of Belgrade, Belgrade, Serbia., Delic D; Clinic for Infectious and Tropical Diseases, Clinical Centre of Serbia, Belgrade, Serbia.; Medical Faculty, University of Belgrade, Belgrade, Serbia.

Publikováno v: Journal of medical biochemistry [J Med Biochem] 2019 Mar 01; Vol. 38 (1), pp. 45-52. Date of Electronic Publication: 2019 Mar 01 (Print Publication: 2019).